Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
Palau Pharma has developed a small molecule H4 receptor antagonist that is about to enter Phase I clinical trials for the treatment of allergic rhinitis and asthma. More
Two types of vaccines for preventing and treating allergic diseases including atopic dermatitis, allergic asthma, allergic rhinitis, allergic conjunctivitis, and urticaria. More
Rubicon has developed a pleasant tasting, robust, orodispersible tablet which can be packed in unit dose blister packs. This provides an excellent opportunity for product differentiation due to improved patient convenience. More
All rights reserved. Terms and Conditions | Contact us
